Bioventix (BVXP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

1,750.00p
   
  • Change Today:
    -50.00p
  • 52 Week High: 2,525.00p
  • 52 Week Low: 1,366.67p
  • Currency: UK Pounds
  • Shares Issued: 5.22m
  • Volume: 8,839
  • Market Cap: £91.44m

Latest ShareCast News

Director dealings: Bioventix chairman raises stake

By Iain Gilbert

Date: Monday 13 Apr 2026

(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

Director dealings: Bioventix chairman raises stake

By Iain Gilbert

Date: Monday 13 Apr 2026

(Sharecast News) - Bioventix revealed on Monday that chairman Ian Nicholson had acquired 1,000 ordinary shares in the AIM-listed biotechnology firm.

China weakness sees profits fall for Bioventix

By Josh White

Date: Monday 27 Oct 2025

(Sharecast News) - Bioventix reported lower annual profits on Monday, as weakness in its core markets, particularly China, offset gains from growing demand for its neurological diagnostic antibodies.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Bioventix Market Data

Currency UK Pounds
Share Price 1,750.00p
Change Today -50.00p
% Change -2.78 %
52 Week High 2,525.00p
52 Week Low 1,366.67p
Volume 8,839
Shares Issued 5.22m
Market Cap £91.44m

Bioventix Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average23.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Price Trend
67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average67.33% below the market average
31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average31.82% below the sector average
Income
60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average60.89% above the market average
33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average33.33% above the sector average
Growth
5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average5.71% below the market average
65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average65.52% below the sector average

Bioventix Dividends

  Latest Previous
  Interim 2nd Interim
Ex-Div 09-Apr-26 06-Nov-25
Paid 24-Apr-26 21-Nov-25
Amount 70.00p 80.00p

Trades for 21-Aug-2026

Time Volume / Share Price
16:44 1,000 @ 1,764.00p
16:24 152 @ 1,706.00p
16:19 99 @ 1,726.20p
15:59 200 @ 1,758.00p
15:57 45 @ 1,800.00p

Bioventix Key Personnel

CEO Peter John Harrison
Chair Ian James Nicholson
CFO Bruce Hiscock

Top of Page